Using Clinical and Echocardiographic Characteristics to Characterize the Risk of Ischemic Stroke in Patients with COVID-19
Connor P. Oates(Icahn School of Medicine at Mount Sinai), Martin E. Goldman(Icahn School of Medicine at Mount Sinai), Nina Kukar(Icahn School of Medicine at Mount Sinai), Dylan Sperling(Icahn School of Medicine at Mount Sinai), Nikola Kocovic(Cardiovascular Institute of the South), Tatyana Danilov(Mount Sinai Beth Israel), Ranbir Singh(Mount Sinai Hospital), Gennaro Giustino(Cardiovascular Institute of the South), Michael S. Miller(Mount Sinai Hospital), Stamatios Lerakis(Emory University), Solomon Bienstock(Cardiovascular Institute of the South), Anton Camaj(Columbia University Irving Medical Center), Laura Stein(Icahn School of Medicine at Mount Sinai), Daniel Benhuri(Mount Sinai Beth Israel), Frans Beerkens(Icahn School of Medicine at Mount Sinai), Lori B. Croft(Mount Sinai Hospital)
Journal of Stroke and Cerebrovascular Diseases
November 8, 2021
Cited by 11
Related Papers
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
|Journal of the American College of Cardiology|2016|438
Characterization of Myocardial Injury in Patients With COVID-19
|Journal of the American College of Cardiology|2020|429
Soluble Urokinase Receptor and Chronic Kidney Disease
|New England Journal of Medicine|2015|415
Coronary In-Stent Restenosis
|Journal of the American College of Cardiology|2022|397
Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: I. Reduced Flow Velocity in the Left Atrial Appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)
|Journal of the American Society of Echocardiography|1999|364